List of Drug Intermediates Manufactured by Ultratech

NAME OF DRUG INTERMEDIATES

CAS#

USED FOR

NAME OF DRUG INTERMEDIATE
  • 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[(2-phthalimido ethoxy)methyl]-1,4-dihydropyridine (Phthaloyl Amlodipine)
CAS#

[88150-62-3]

USED FOR

Amlodipine Besilate / Amlodipine Maleate

  • Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N- (pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate HCl
CAS#

[211914-50-0]

USED FOR

Dabigatran Etexilate Mesilate

  • Cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-l-ylmethyl)- 1,3- dioxolan-4-yl]methyl-4-methyl benzenesulphonate (CisTosylate)
CAS#

[134071-44-6]

USED FOR

Ketoconazole

  • (6R.12aR)-methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1 (3,4-methylenedioxyphenyl)9H-pyrido-[3,4-b]- indole-3-Carboxylate
CAS#

[171489-59-1]

USED FOR

Tadalafil

  • N-[(4s,6s)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno [2,3-b] thiopyran-4-yl]acetamide

CAS#

[147086-83-7]

USED FOR

Dorzolamide HCl

  • 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]- 1H-benzimidazole

CAS#

[103577-40-8]

USED FOR

Lansoprazole

  • (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin3-one hydrochloride

CAS#

[898543-06-1]

USED FOR

Rivaroxaban

  • Alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol

CAS#

[24155-42-8]

USED FOR

Miconazole / Voriconazole / Tioconazole

  • 1,4,7,10-tetraazacyclododecane (Cyclen)


CAS#

[294-90-6]

USED FOR

DOTA (Tetraxetan)/ Gadobutrol/Gadoterate

  • 2-[4-(2-Chloroethyl) phenyl]-2-methyl-propanoic acid

CAS#

[2199440-16-7]

USED FOR

Bilastine

  • 2-oxo-5-vinylpyrrolidine-3-carboxamide

CAS#

[71107-19-2]

USED FOR

Vigabatrin

  • 5-(2-Fluorophenyl)pyrrole-3-carboxaldehyde

CAS#

[881674-56-2]

USED FOR

Vonoprazan

  • 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]-piperazine

CAS#

[508233-74-7]

USED FOR

Vortioxetine HBr

Products protected by valid patents are not offered for sale in countries where the sale of such products constitute a patent infringement and the liability for patent infringement is exclusively understood at buyer's risk.